Cargando…
Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells
Cis-diamminedichloroplatinum (II) (cisplatin) is a widely used anti-tumor drug for the treatment of a broad range of human malignancies with successful therapeutic outcomes for head and neck, ovarian, and testicular cancers. It has been found to inhibit cell cycle progression and to induce oxidative...
Autores principales: | Kumar, Sanjay, Tchounwou, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747365/ https://www.ncbi.nlm.nih.gov/pubmed/26486083 |
Ejemplares similares
-
Preclinical Assessment of Low Doses of Cisplatin in the Management of Acute Promyelocytic Leukemia
por: Dasari, Shaloam R, et al.
Publicado: (2015) -
Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells
por: Velma, Venkatramreddy, et al.
Publicado: (2016) -
Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
por: Yedjou, Clement, et al.
Publicado: (2009) -
p53 as a unique target of action of cisplatin in acute leukaemia cells
por: Kumar, Sanjay, et al.
Publicado: (2022) -
Trisenox Disrupts MDM2-DAXX-HAUSP Complex and Induces Apoptosis in a Mouse Model of Acute Leukemia
por: Kumar, Sanjay, et al.
Publicado: (2020)